Elzbieta Rode-Walajtys
75 Koszykowa Str
Warsaw, MZ 00664, Poland
Warsaw, MZ 00664, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications
Celecoxib substituted biotinylated poly(amidoamine) G3 dendrimer as potential treatment for temozolomide resistant glioma therapy and anti-nematode agent.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: May 05, 2020
The Effect of Biotinylated PAMAM G3 Dendrimers Conjugated with COX-2 Inhibitor (celecoxib) and PPARγ Agonist (Fmoc-L-Leucine) on Human Normal Fibroblasts, Immortalized Keratinocytes and Glioma Cells in Vitro.
Journal: Molecules (Basel, Switzerland)
Published: October 01, 2019
Synthesis and Different Effects of Biotinylated PAMAM G3 Dendrimer Substituted with Nimesulide in Human Normal Fibroblasts and Squamous Carcinoma Cells.
Journal: Biomolecules
Published: July 18, 2019
Evaluation of the localization and biological effects of PAMAM G3 dendrimer-biotin/pyridoxal conjugate as HaCaT keratinocyte targeted nanocarrier.
Journal: Acta biochimica Polonica
Published: January 12, 2019
Biotinylated PAMAM G3 dendrimer conjugated with celecoxib and/or Fmoc-l-Leucine and its cytotoxicity for normal and cancer human cell lines.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: May 08, 2018
Monocyte/Macrophage: NK Cell Cooperation-Old Tools for New Functions.
Journal: Results and problems in cell differentiation
Published: April 30, 2017
The effect of G3 PAMAM dendrimer conjugated with B-group vitamins on cell morphology, motility and ATP level in normal and cancer cells.
Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Published: November 30, 2016
Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs.
Journal: Bioorganic & medicinal chemistry
Published: July 05, 2016
Different patterns of nuclear and mitochondrial penetration by the G3 PAMAM dendrimer and its biotin-pyridoxal bioconjugate BC-PAMAM in normal and cancer cells in vitro.
Journal: International journal of nanomedicine
Published: September 18, 2015
Properties of phosphorylated thymidylate synthase.
Journal: Biochimica et biophysica acta
Published: May 17, 2015
In vitro cytotoxicity of the ternary PAMAM G3-pyridoxal-biotin bioconjugate.
Journal: International journal of nanomedicine
Published: December 31, 2013
Last Updated: 09/26/2026